Optimal pharmacologic treatment of the critically ill patient with obstructive airways disease

American Journal of Medicine

Volumn 100, Issue 1 A, 1996, Pages S54-S61

  Siefkin, A D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ATROPINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BITOLTEROL; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FENOTEROL; IPRATROPIUM BROMIDE; ISOETARINE; ISOPRENALINE; METHYLXANTHINE DERIVATIVE; ORCIPRENALINE; PIRBUTEROL; SALBUTAMOL; SALMETEROL; TERBUTALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT;

AIRWAY RESISTANCE; ARTERIAL GAS; ARTIFICIAL VENTILATION; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CRITICAL ILLNESS; HEART MUSCLE OXYGEN CONSUMPTION; HOSPITALIZATION; HUMAN; HYPOKALEMIA; INHALATIONAL DRUG ADMINISTRATION; INSOMNIA; INTENSIVE CARE UNIT; LUNG FUNCTION TEST; MULTIPLE ORGAN FAILURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TACHYCARDIA; TREMOR; VISUAL IMPAIRMENT; XEROSTOMIA; DRUG COMBINATION; LUNG VENTILATION; PATHOPHYSIOLOGY; REVIEW;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ASTHMA; BRONCHODILATOR AGENTS; CRITICAL ILLNESS; DRUG COMBINATIONS; HUMANS; IPRATROPIUM; LUNG DISEASES, OBSTRUCTIVE; MUSCARINIC ANTAGONISTS; PULMONARY VENTILATION;

EID: 0030605324     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)80097-0     Document Type: Conference Paper

References (37)

1. Siefkin A.D. Using pulmonary function testing in the diagnosis and treatment of asthma Clin Rev Allergy 8 1990 179 196
2. Clark N.M. Evans D. Mellins R.B. Patient use of peak flow monitoring Am Rev Respir Dis 145 1992 722 725
3. Barnes P.J. Modulation of neurotransmission in airways Physiol Rev 72 1992 699 729
4. Siefkin A.D. Asthma: office testing, differential diagnosis, patient classification, patient education, first-line therapy, drug delivery techniques, and management in the difficult asthmatic. (A three part paper) Mod Med 59 1991 38 77
5. Kelly H.W. Murphy S. Beta-adrenergic agonists for acute severe asthma Ann Pharmacother 26 1992 81 90
6. Salzman G.A. Steele M.T. Pribble J.P. Elenbaas R.M. Pyszczynski D.R. Aerosolized metaproterenol in the treatment of asthmatics with severe airflow obstruction: comparison of two delivery methods Chest 95 1989 1017 1020
7. Berry R.B. Shinto R.A. Wong F.H. Despars J.A. Light R.W. Nebulized versus spacer for bronchodilator delivery in patients hospitalized for acute exacerbation of COPD Chest 96 1989 1241 1246
8. 2 in children with severe asthma treated with continuously nebulized terbutaline J Allergy Clin Immunol 81 1988 1101 1105
9. Taylor D.R. Wilkins G.T. Herbison G.P. Flannery E.M. Interaction between corticosteroids and β-agonist drugs: biochemical and cardiovascular effects in normal subjects Chest 102 1992 519 524
10. Sears M. Taylor D.R. Print C.O. Regular inhaled beta-agonist treatment in bronchial asthma Lancet 336 1990 1391 1396
11. Spitzer W.O. Suissa S. Ernest P. The use of beta-agonists and the risk of death or near death from asthma N Engl J Med 326 1992 501 506
12. Pak C.C.F. Kradjan W.A. Lakshminarayan S. Marini J.J. Inhaled atropine sulfate; dose-response characteristics in adult patients with chronic airflow obstruction Am Rev Respir Dis 125 1982 331 334
13. Harrison L.I. Smallridge R.C. Lasseter K.C. Comparative absorption of inhaled and intramuscularly administered atropine Am Rev Respir Dis 134 1986 254 257
14. Siefkin A.D. Inhaled ipratropium bromide in the management of chronic obstructive airways disease IM: Internal Medicine for the Specialist 10 1989 1 11
15. Braun S.R. McKenzie W.I.N. Copeland C. Knight L. Ellersieck M. A comparison of the effect of ipratropium bromide and albuterol in the treatment of chronic obstructive airway disease Arch Intern Med 149 1989 544 554
16. Ward M.J. Macfarlane J.T. Davies D. A place for ipratropium bromide in the treatment of severe acute asthma Br J Dis Chest 79 1985 374 378
17. Mann N.P. Hiller E.J. Ipratropium bromide in children with asthma Thorax 37 1982 72 74
18. Ihre E. Larsson K. Airways responses to ipratropium bromide do not vary with time in asthmatic subjects: studies of interindividual and intraindividual variation of bronchodilatation and protection against histamine-induced bronchoconstriction Chest 97 1990 46 51
19. Kradjan W.A. Driesner I.N.K. Abuan T.H. Emmick G. Schoene R.B. Effect of age on bronchodilator response Chest 101 1992 1545 1551
20. Ghafouri M.A. Patil K.D. Kass I. Sputum changes associated with the use of ipratropium bromide Chest 86 1984 387 393
21. 2-agonist Am Rev Respir Dis 132 1985 845 847
22. Gross N.J. Bankwala Z. Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease; comparison with a beta-adrenergic agent Am Rev Respir Dis 136 1987 1091 1094
23. Gross N.J. Petty T.L. Friedman M. Skorodin M.S. Silvers G.W. Donohue J.F. Dose response to ipratropium bromide as a nebulized solution in patients with chronic obstructive pulmonary disease: a three center study Am Rev Respir Dis 139 1989 1188 1191
24. Lightbody I.M. Ingram C.G. Legge J.S. Johnston R.N. Ipratropium bromide, salbutamol, and prednisolone in bronchial asthma and chronic bronchitis Br J Dis Chest 72 1978 181 186
25. Bruderman I. Cohen-Aronovski R. Smorzik J. A comparative study of various combinations of Ipratropium bromide and metaproterenol in allergic asthmatic patients Chest 83 1983 208 210
26. 2-adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence N Engl J Med 315 1986 735 739
27. Bryant D.H. Nebulized ipratropium bromide in the treatment of acute asthma Chest 88 1985 24 29
28. Reisman J. Galdes-Sebaldt M. Kazim F. Canny G. Levison H. Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children J Allergy Clin Immunol 81 1988 16 20
29. Naspitz C.K. Sole D. Treatment of acute wheezing and dyspnea attacks in children under 2 years old: Inhalation of fenoterol plus ipratropium bromide versus fenoterol J Asthma 29 1992 253 258
30. Kerem E. Bentur L. Levison H. Jaffe D. Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis Pediatrics 90 1992 920 923
31. Rebuck A.S. Chapman K.R. Abboud R. Nebulized anticholinergic and sympathomimetic treatments of asthma and chronic obstructive airways disease in the emergency room Am J Med 82 1987 59 64
32. Karpel J.P. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD Chest 99 1991 871 876
33. Shrestha M. O'Brien T. Haddox R. Gourlay H.S. Reed G. Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to beta-agonist therapy Ann Emerg Med 20 1991 1206 1209
34. Nisar M. Earis J.E. Pearson M.G. Calverly P.M.A. Acute bronchodilator trials in chronic obstructive pulmonary disease Am Rev Respir Dis 146 1992 555 559
35. Ohrui T. Yanai M. Sekizawa K. Morikawa M. Sasaki H. Takishima T. Effective site of bronchodilation by beta-adrenergic and anticholinergic agents in patients with chronic obstructive pulmonary disease: direct measurement of intrabronchial pressure with a new catheter Am Rev Respir Dis 146 1992 88 91
36. Konig P. Spacer devices used with metered-dose inhalers: breakthrough or gimmick Chest 88 1985 276 284
37. Rau J.L. Harwood R.J. Groff J.L. Evaluation of a reservoir device for metered-dose bronchodilator delivery in intubated adults: an in vitro study Chest 102 1992 924 930